Exact Sciences Showcases Breadth of Early Detection and Trea

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced new data supporting its cancer tests and...

Related Keywords

Canada , Illinois , United States , Chicago , America , American , Federico Maiardi , Stephanie Spanos , Kevin Conroy , Megan Jones , Sciences Corp , Sciences On Facebook , American Society Of Clinical Oncology , Linkedin , Meeting Library , World Health Organization , Sciences On Twitter Exactsciences , Sciences Company , Nasdaq , Exchange Commission , Prnewswire Exact Sciences Corp , Genomic Health Inc , Fashion Analytics , Sciences Corporation , Clinical Oncology , Annual Meeting , Exact Sciences , Exact Science , Mayo Clinic , Oncotype Map , Pan Cancer Tissue , Gastrointestinal Cancer , Hematologic Malignancies , Chronic Lymphocytic , Developmental Therapeutics , Molecularly Targeted Agents , Breast Cancer , Lung Cancer , Non Small Cell , Risk Reduction , Genitourinary Cancer , Recurrence Score , Prostate Score , Oncomap Extra , Genomic Health , Risk Factors , Annual Report , Quarterly Reports , World Health , Accessed May , Latin America , Exact Sciences Corp , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Otc , Mallcap , Clinical Trials Amp Medical Discoveries , Trade Show News ,